Microbial Protein Patents

Microbial / single-cell protein patents cover gas-fermentation/CO2-protein innovations; single-cell-protein/biomass innovations; mycoprotein innovations; and strain/bioprocess and food-formulation innovations — with IP held by single-cell-protein and alternative-protein companies (in a field growing protein-rich microbial biomass as food and feed). WHY MICROBIAL PROTEIN: the world needs more PROTEIN with a far smaller environmental footprint than animal agriculture (which uses huge land/water and emits greenhouse gases); MICROBIAL or SINGLE-CELL PROTEIN grows PROTEIN-rich microbial BIOMASS via fermentation — where the microbe ITSELF is harvested as the food/feed — and notably can grow microbes on GASES (CO2 + hydrogen, or methane) instead of crops, DECOUPLING protein production from farmland, weather, and crops (making 'protein from air/electricity' with tiny land/water use); a sustainable route to food and animal feed. It's distinct from 'PRECISION FERMENTATION' (which engineers microbes to secrete SPECIFIC molecules like dairy proteins) — here the WHOLE organism is the protein. MAJOR HOLDERS: SOLAR FOODS (Solein — protein from CO2 + hydrogen via gas fermentation), AIR PROTEIN, CALYSTA (methane→protein, FeedKind for feed), QUORN/Marlow (mycoprotein — fungal), UNIBIO, plus feed/agriculture players. Gas fermentation/CO2-protein, single-cell protein/biomass, mycoprotein, strain/bioprocess, and food/feed formulation are the core microbial-protein patent domains — and gas fermentation, strains/bioprocess, and food formulation are the open whitespace.

Gas-fermentation/CO2-protein innovations; single-cell-protein/biomass innovations; mycoprotein innovations; and feedstock innovations represent core microbial-protein patent domains — and the distinctive way of making the protein (especially from gases) and the type of biomass are the foundational, high-value capabilities. GAS-FERMENTATION / CO2-PROTEIN PATENTS: the distinctive approach — growing microbes on GASES as their carbon/energy source: hydrogen-oxidizing bacteria on CO2 + HYDROGEN (often hydrogen from renewable electrolysis — 'food from air and electricity' — Solar Foods/Air Protein), or methanotrophs on METHANE (Calysta); gas-fermentation bioprocess, gas-transfer/bioreactor design, and the strains are core, high-value IP (gas fermentation is the distinctive, land-decoupled, defensible approach — and gas mass-transfer is a real engineering challenge). SINGLE-CELL-PROTEIN / BIOMASS PATENTS: growing and harvesting microbial BIOMASS itself as protein — production strains, growth/fermentation, biomass harvesting/processing, and protein content/quality; single-cell-protein methods are core IP (the biomass IS the product). MYCOPROTEIN PATENTS: FUNGAL/filamentous biomass (Quorn's Fusarium mycoprotein) — its filamentous structure gives meat-like TEXTURE (a key advantage for whole-cut alternatives) — strains, fermentation, and texture; mycoprotein methods are high-value IP (texture is a differentiator for alt-protein). FEEDSTOCK PATENTS: alternative feedstocks (gases, agricultural/industrial byproducts, sugars) and using them efficiently/cheaply; feedstock methods are valuable (feedstock cost drives economics). Gas fermentation/CO2-protein, single-cell protein/biomass, mycoprotein, and feedstock are the highest-value core IP because the distinctive (especially gas-based) production route and the biomass type are exactly what define a microbial-protein product.

Strain/bioprocess innovations; food/feed-formulation innovations; cost/scale-up/techno-economics innovations; and safety/regulatory and sustainability innovations represent additional microbial-protein patent domains — and improving the strains/process, making the biomass into palatable food, and (above all) cost are where commercial viability is won. STRAIN / BIOPROCESS PATENTS: the production STRAINS (high-yield, fast-growing, high-protein, possibly engineered) and the FERMENTATION process — bioreactor design (especially for gas fermentation's gas-transfer challenge), continuous vs batch, productivity/yield, and contamination control; strain/bioprocess methods are core, high-value IP (yield and productivity drive cost). FOOD / FEED-FORMULATION PATENTS: turning microbial BIOMASS into PALATABLE, usable food/feed — improving TASTE and TEXTURE (microbial biomass can taste/smell off), reducing RNA/nucleic-acid content (high microbial RNA can cause health issues at high intake — a real processing requirement for human food), removing off-flavors, and formulating ingredients; food-formulation methods are high-value IP (palatability and safety determine whether people/animals will eat it). COST / SCALE-UP / TECHNO-ECONOMICS PATENTS: the make-or-break — achieving COST-competitive production at SCALE (microbial protein must compete with cheap soy/animal protein), capital-efficient bioreactors, and energy/feedstock efficiency (gas fermentation's economics hinge on cheap renewable hydrogen/electricity); cost/scale-up methods are high-value IP (techno-economics is the central commercial challenge — many alt-protein ventures fail on cost/scale, like synbio cautionary tales). SAFETY / REGULATORY / SUSTAINABILITY PATENTS: food-SAFETY (novel-food regulatory approval — FDA GRAS/EU novel food), and quantifying the SUSTAINABILITY (land/water/carbon) advantage; safety/regulatory and sustainability methods are valuable. Strain/bioprocess, food formulation, cost/scale-up, and safety/regulatory are the highest-value enabling IP because productive strains, palatable safe food, and cost-competitive scale are exactly what determine whether microbial protein succeeds commercially.

Microbial protein startup IP strategy must navigate Solar Foods/Calysta/Quorn and feed-industry portfolios, a long history of single-cell-protein prior art (single-cell protein was explored decades ago — the modern gas-fermentation, strains, cost, and food-formulation advances are the novelty), the precision-fermentation distinction (don't confuse with molecule-secreting precision fermentation — this is whole-biomass protein), the COST/scale-up reality (THE make-or-break — microbial protein must compete with cheap commodity protein; many alt-protein/synbio ventures failed on economics/scale — Amyris/Zymergen-style cautionary tales), the gas-fermentation engineering challenge (gas mass-transfer, and dependence on cheap renewable hydrogen/electricity for CO2 routes), the food-safety/regulatory path (novel-food approval, RNA reduction), the palatability requirement (taste/texture), and a landscape where gas fermentation, strains/bioprocess, food formulation, and cost/scale are the durable assets; understand that single-cell protein is old, so the durable IP is in gas-fermentation bioprocess, high-yield strains, cost-reducing scale-up, food formulation (taste/texture/RNA/safety), and mycoprotein texture — with process/strain know-how and techno-economics often the real determinants, and that cost-at-scale, palatability, safety/regulatory, and sustainability matter as much as patents; identify whitespace in gas fermentation, cost/scale, and formulation. MICROBIAL-PROTEIN STARTUP IP STRATEGY: SINGLE-CELL PROTEIN IS OLD — GAS-FERMENTATION BIOPROCESS, HIGH-YIELD STRAINS, COST-REDUCING SCALE-UP, FOOD FORMULATION, AND MYCOPROTEIN TEXTURE ARE THE IP: patent gas-fermentation/bioreactor methods, production strains, cost/scale-up, food formulation (taste/texture/RNA/safety), and texture methods; COST AT SCALE IS THE MAKE-OR-BREAK (LEARN FROM SYNBIO FAILURES): microbial protein must compete with cheap commodity soy/animal protein — many alt-protein/synbio ventures failed on ECONOMICS/SCALE (Amyris/Zymergen-style) — cost-reducing process/scale IP is the most valuable, and techno-economics matters as much as any patent; GAS FERMENTATION (CO2/METHANE→PROTEIN) IS THE DISTINCTIVE, HIGH-VALUE WHITESPACE: 'food from air/electricity' decoupled from farmland (Solar Foods/Calysta) is the differentiated approach — gas-transfer bioreactor + strain IP is defensible (but economics depend on cheap renewable hydrogen/electricity); DON'T CONFUSE WITH PRECISION FERMENTATION: this is WHOLE-biomass protein (the microbe IS the food), not molecule-secreting precision fermentation — position/IP accordingly; STRAINS/BIOPROCESS DRIVE YIELD AND COST: high-yield, fast-growing, high-protein strains and efficient fermentation are core (yield = cost); FOOD FORMULATION (TASTE/TEXTURE/RNA/SAFETY) DETERMINES ADOPTION: microbial biomass must be palatable and safe (RNA reduction for human food) — formulation IP is high-value (people won't eat unpalatable protein); MYCOPROTEIN TEXTURE IS A DIFFERENTIATOR: filamentous fungal texture (Quorn) enables meat-like whole-cuts — texture IP is valuable; SAFETY/REGULATORY (NOVEL FOOD) IS A GATE: FDA GRAS/EU novel-food approval is required — regulatory-ready methods matter; PROCESS/STRAIN KNOW-HOW IS OFTEN THE MOAT: fermentation process parameters and strains (some trade-secret) drive economics; COST/PALATABILITY/SAFETY/SUSTAINABILITY MATTER AS MUCH AS PATENTS: cost-at-scale, taste/texture, regulatory approval, and proven sustainability drive adoption; WHEN TO PATENT (OR KEEP SECRET): NOVEL FERMENTATION/STRAIN/FORMULATION/SCALE WITH MEASURED RESULTS: file (or trade-secret process/strains) once a method shows measured results (protein yield/productivity + production cost-per-kg + feedstock/energy efficiency + palatability/texture + RNA/safety) — measured production cost-per-kg, protein yield/productivity, and palatability/safety are the critical microbial-protein IP metrics; KEY FTO CHECKLIST: Solar Foods (Solein/CO2+H2); Air Protein; Calysta (methane/FeedKind); Quorn/Marlow (mycoprotein); Unibio; single-cell-protein historical prior art; gas fermentation (CO2+hydrogen/methane)/gas-transfer bioreactor; single-cell protein/biomass strain/harvest; mycoprotein (fungal/filamentous/texture); strain/bioprocess (yield/productivity/continuous/contamination); food/feed formulation (taste/texture/RNA reduction/off-flavor); cost/scale-up/techno-economics; novel-food safety/regulatory (GRAS/EU novel food); sustainability (land/water/carbon); process/strain know-how (trade-secret).